Medical Device Investing Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market
Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor